Home / Editorial Policy

Editorial Policy

How we research, write, update and correct GLP1Rated content.

Independence

We may earn a commission when you sign up through some links on this site, at no cost to you. Rankings and scores follow our method alone, and no company can pay for a higher score. Featured partner placements are labelled and sit outside our rankings.

Sources

Medical facts come from FDA statements, FDA-approved drug labels and peer-reviewed or published clinical trials, and we link to them. Company details come from each company's own website, pricing pages and terms. We note anything we could not confirm.

Who writes our content

GLP1Rated is produced by the Andiamo Group Ltd editorial team. We are not medical professionals, and our content is not medically reviewed. It is general information, not medical advice.

Scores

Providers are scored with our published method. Companies cannot pay for a score or ranking.

Updates

We recheck prices and key facts regularly and show the date on each page.

Corrections

If you spot an error, email support@and-iamo.com with a source. We review every correction request and update pages when the evidence supports it.

Language we avoid

We don't promise results, describe compounded drugs as FDA-approved or equivalent to brand-name medicines, or present supplements as treatments.

The GLP-1 brief

Price drops, new approvals and provider changes, once a week. No spam, unsubscribe any time.